Engineering enzyme specificity

Current Opinion in Chemical Biology

Volumn 2, Issue 1, 1998, Pages 127-132

  Harris, Jennifer L ^a   Craik, Charles S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME;

CHEMISTRY; ENZYME SPECIFICITY; HUMAN; PROTEIN ENGINEERING; REVIEW;

ENZYMES; HUMANS; PROTEIN ENGINEERING; SUBSTRATE SPECIFICITY;

EID: 0031993437     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(98)80044-6     Document Type: Article

References (47)

1. Dalal S, Balasubramanian S, Regan L: Protein alchemy: changing beta-sheet into alpha-helix. Nat Struct Biol 1997, 4:548-552.
2. Betz SF, Liebman PA, DeGrado WF: De novo design of native proteins: characterization of proteins intended to fold into antiparallel, rop-like, four-helix bundles. Biochemistry 1997, 36:2450-2458.
3. Severin K, Lee Dh, Kennan AJ, Ghadiri MR: A synthetic peptide ligase. Nature 1997, 389706-709. The de novo design of a 33 amino acid synthetic peptide that is capable of catalyzing the ligation of suitably activated peptides is described. Specificity and correct positioning of the substrates are accomplished through coiled-coil interactions.
4. Pinto AL, Hellinga HW, Caradonna JP: Construction of a catalytically active iron superoxide dismutase by rational protein design. Proc Natl Acad Sci USA 1997, 94:5562-5567. Superoxide dismutase activity was engineered into the hydrophobic interior of thioredoxin. The introduction of this activity was accomplished by the rational design of a nonheme iron (III) binding site, using only strict geometrical constraints.
5. El Hawrani AS, Sessions RB, Moreton KM, Holbrook JJ: Guided evolution of enzymes with new substrate specificities. J Mol Biol 1996, 264:97-110.
6. Dufour E, Storer AC, Menard R: Engineering nitrile hydratase activity into a cysteine protease by a single mutation. Biochemistry 1995, 34:16382-16388.
7. Huang W, Petrosino J, Hirsch M, Shenkin PS, Palzkill T: Amino acid sequence determinants of beta-lactamase structure and activity. J Mol Biol 1996, 258:688-703. In this paper, the authors show the power of selection by systematically mutating, through site-directed random mutagenesis, each of the 263 amino acid residues of TEM-1 β-lactamase. Through this exhaustive study, they concluded that only 43 of the amino acid residues cannot tolerate substitution.
8. Kast P, Asif-Ullah M, Jiang N, Hilvert D: Exploring the active site of chorismate mutase by combinatorial mutagenesis and selection: the importance of electrostatic catalysis. Proc Natl Acad Sci USA 1996, 93:5043-5048. In this paper, the authors demonstrate the important role of electrostatic transition state stabilization in the chorismate mutase catalyzed chorismate rearrangement. Two amino acid positions near the active site were randomized. A positive charge at either position was shown to be essential for catalysis. This analysis led the authors to postulate that the electrostatic nature of the transition state in the enzyme-catalyzed reaction was similar to that in the uncatalyzed reaction.
9. Lawson SL, Wakarchuk WW, Withers SG: Positioning the acid/base catalyst in a glycosidase: studies with Bacillus circulans xylanase. Biochemistry 1997, 36:2257-2265. In this study, the dependence of distance between the two catalytic glutamates of the enzyme xylanase was explored through site-directed mutagenesis and the introduction of non-natural amino acid sidechains. Lengthening the distance through a mutation of the nucleophilic glutamate to aspartate as well as shortening the distance through mutation of the glutamate to a cysteine (which was then treated with iodoacetate to give the carboxymethylated cysteine) led to decreased xylan hydrolysis.
10. Chang TK, Jackson DY, Burnier JP, Wells JA: Subtiligase: a tool for semisynthesis of proteins. Proc Natl Acad Sci USA 1994, 91:12544-12548.
11. Arnold FH, Moore JC: Optimizing industrial enzymes by directed evolution. Adv Biochem Eng Biotechnol 1997, 58:1-14.
12. Cantu C III, Huang W, Palzkill T: Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime. J Biol Chem 1996, 271:22538-22545.
13. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY: Understanding, improving and using green fluorescent proteins. Trends Biochem Sci 1995, 20:448-455.
14. Heim R, Tsien RY: Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol 1996, 6:178-182. Variants of the green fluorescent protein (GFP) with different fluroescence properties were generated through error-prone PCR. Mutants were selected for brightness and shifts in excitation and emission wavelengths. The authors demonstrate that the variant GFPs are capable of fluorescence resonance energy transfer, thereby making them a useful tool for monitoring protein-protein interactions.
15. 4-fold increased preference over the wild type enzyme for a cationic substrate. This is an improvement over previous efforts to achieve this effect using natural amino acid replacement.
16. Zhao H, Arnold FH: Combinatorial protein design: strategies for screening protein libraries. Curr Opin Struct Biol 1997, 7:480-485. This paper is a good overview of the current methods used to search large protein libraries.
17. Shah K, Liu Y, Deirmengian C, Shokat KM: Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. Proc Natl Acad Sci USA 1997, 94:3565-3570. The tyrosine kinase v-Src is rationally designed to accept ATP analogs derivatized in the N-6 position. This strategy provides a tool for identifying the direct substrates of a kinase.
18. Liu Y, Shah K, Yang F, Witucki L, Shokat KM: Engineering Src family protein kinases with unnatural nucleotide specificity. Chem Biol 1998, 5:91-101.
19. Klemba M, Regan L: Characterization of metal binding by a designed protein: single ligand substitutions at a tetrahedral Cys2His2 site. Biochemistry 1995, 34:10094-100100.
20. Braha O, Walker B, Cheley S, Kasianowicz JJ, Song L, Gouaux JE, Bayley H: Designed protein pores as components for biosensors. Chem Biol 1997, 4:497-505.
21. Bonagura CA, Sundaramoorthy M, Pappa HS, Patterson WR, Poulos TL: An engineered cation site in cytochrome C peroxidase alters the reactivity of the redox active tryptophan. Biochemistry 1996, 35:6107-6115.
22. Willett WS, Brinen LS, Fletterick RJ, Craik CS: Delocalizing trypsin specificity with metal activation. Biochemistry 1996, 35:5992-5998. A tridentate metal binding site is designed into trypsin to allow for metal-assisted substrate specificity.
23. Brinen LS, Willett WS, Craik CS, Fletterick RJ: X-ray structures of a designed binding site in trypsin show metal-dependent geometry. Biochemistry 1996, 35:5999-6009. The three-dimensional structures of a metal-assisted trypsin variant complexed to the substrate-like inhibitor ecotin and a divalent metal ion (zinc(II), nickel(II) and copper(II)) are described.
24. Ballinger MD, Tom J, Wells JA: Designing subtilisin BPN′ to cleave substrates containing dibasic residues. Biochemistry 1995, 34:13312-13319.
25. Ballinger MD, Tom J, Wells JA: Furilisin: a variant of subtilisin BPN′ engineered for cleaving tribasic substrates. Biochemistry 1996, 35:13579-13585. Tribasic cleavage specificity was designed into subtilisin. Synergy between the substrate subsites of the variant enzyme was observed.
26. Chen R, Greer A, Dean AM: Redesigning secondary structure to invert coenzyme specificity in isopropylmalate dehydrogenase. Proc Natl Acad Sci USA 1996, 93:12171-12176. Differences in secondary structure between homologous decarboxylating dehydrogenases were used to alter the cofactor specificity of isopropylmalate dehydrogenase.
27. Hurley JH, Chen R, Dean AM: Determinants of cofactor specificity in isocitrate dehydrogenase: structure of an engineered NADP+ → NAD+ specificity-reversal mutant Biochemistry 1996, 35:5670-5678.
28. Mace JE, Wilk BJ, Agard DA: Functional linkage between the active site of alpha-lytic protease and distant regions of structure: scanning alanine mutagenesis of a surface loop affects activity and substrate specificity. J Mol Biol 1995, 251:116-134.
29. Perona JJ, Hedstrom L, Rutter WJ, Fletterick RJ: Structural origins of substrate discrimination in trypsin and chymotrypsin. Biochemistry 1995, 34:1489-1499.
30. Tsiang M, Paborsky LR, Li W. X, Jain AK, Mao CT, Dunn KE, Lee DW, Matsumura SY, Matteucci MD, Coutre SE et al.: Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry 1996, 35:16449-16457. A single mutation in thrombin shifted the substrate specificity for activating the anticoagulation pathway 130-fold. In addition, an increase in half-life was observed and attributed to decreased clearance by the inhibitor antithrombin III.
31. Gibbs CS, Coutre SE, Tsiang M, Li WX, Jain AK, Dunn KE, Law VS, Mao CT, Matsumura SY, Mejza SJ et al.: Conversion of thrombin into an anticoagulant by protein engineering. Nature 1995, 378:413-416.
32. Christians FC, Dawson BJ, Coates M M, Loeb LA: Creation of human alkyltransferases resistant to O6-benzylguanine. Cancer Res 1997, 57:2007-2012. Region-directed random mutagenesis and resistance selection were used to create an O6-benzylguanine (BG) resistant alkyltransferase. This variant enzyme could prove useful in protecting stem cells from combination chemotherapy, where tumors are sensitized with BG and then treated with alkylating agents.
33. Wentworth P, Datta A, Blakey D, Boyle T, Partridge LJ, Blackburn GM: Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing. Proc Natl Acad Sci USA 1996, 93:799-803.
34. Black ME, Newcomb TG, Wilson HM, Loeb LA: Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci USA 1996, 93:3525-3529.
35. Moore JC, Arnold FH: Directed evolution of a para-nitrobenzyl esterase for aqueous-organic solvents. Nat Biotechnol 1996, 14:458-467. Random mutagenesis was used to increase the total para-nitrobenzyl ester hydrolysis activity of subtilisin in 30% dimethylformamide ∼50-fold.
36. Crameri A, Whitehorn EA, Tate E, Stemmer WPC: Improved green fluorescent protein by molecular evolution using DNA shuffling.. Nat Biotechnol 1996, 14:315-319.
37. Zhao H, Arnold FH: Optimization of DNA shuffling for high fidelity recombination. Nucleic Acids Res 1997, 25:1307-1308.
38. Zhao H, Li Y, Arnold FH: Strategy for the directed evolution of a peptide ligase. Ann NY Acad Sci 1996, 799:1-5.
39. You L, Arnold FH: Directed evolution of subtilisin E in Bacillus subtilis to enhance total activity in aqueous dimethylformamide. Protein Eng 1996, 9:77-83.
40. Smith GP: Applied evolution. The progeny of sexual PCR. Nature 1994, 370:324-325.
41. Stemmer WP: Rapid evolution of a protein in vitro by DNA shuffling. Nature 1994, 370:389-391.
42. Stemmer WP: DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc Natl Acad Sci USA 1994, 91:10747-10751.
43. Zhang JH, Dawes G, Stemmer WP: Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening. Proc Natl Acad Sci USA 1997, 94:4504-4509.
44. Crameri A, Dawes G, Rodriguez E Jr, Silver S, Stemmer WP: Molecular evolution of an arsenate detoxification pathway by DNA shuffling. Nat Biotechnol 1997, 15:436-438. In vitro DNA shuffling of multiple genes in an arsenic detoxification operon was used to increase in vivo resistance. This study showed the relevance of this method for selecting multiple complex traits such as substrate specificity and protein stability, or substrate specificity and secretion efficiency, or substrate specificity and expression.
45. Wade H, Scanlan TS: The structural and functional basis of antibody catalysis. Annu Rev Biophys Biomol Struct 1997, 26:461-493.
46. O'Neil KT, Hoess RH: Phage display: protein engineering by directed evolution. Curr Opin Struct Biol 1995, 5:443-449.
47. Hanes J, Pluckthun A: In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci USA 1997, 94:4937-4942.